Search results for " obesity"

showing 10 items of 504 documents

Qualitative Evaluation, with French Healthcare and Childcare Professionals, of a Brochure Containing the Latest Official Child Feeding Recommendation…

2021

Meeting abstract number 4 in the 30. Annual Congress of European Chilhood Obesity Group (ECOG), 2021/11/10-13, Budapest (Hungary).

[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatricschild feeding recommendations[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionchildhood obesityComputingMilieux_MISCELLANEOUS
researchProduct

Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents.

2014

Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence…

adipose tissue adipokines obesity lipoproteins
researchProduct

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Pat…

2018

: Obesity predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke, which are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications.

adolescent hypertensioncardiovascular riskmedicine.medical_specialtyBiomedical ResearchConsensusPhysiologyheart failurePhysical exerciseDisease030204 cardiovascular system & hematologysudden cardiac deathSudden cardiac death03 medical and health sciencesbody weight0302 clinical medicineRisk FactorsDiabetes mellitusWeight LossMetabolically healthy obesityDiabetes MellitusInternal MedicinemedicineHumansatrial fibrillation030212 general & internal medicineObesityIntensive care medicineExerciseStrokeDyslipidemiasdiabetesbusiness.industrydyslipidemiacardiorespiratory fitnemedicine.diseaseObesityStrokediabeteCardiovascular DiseasesHeart failureHypertensionmetabolically healthy obesityCardiology and Cardiovascular Medicinebusinesschronic kidney disease
researchProduct

A Research Agenda: The Changing Relationship Between Body Weight and Health in Aging

2008

aging sarcopenic obesity sarcopenia
researchProduct

The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage

2007

High blood pressure is often associated with various metabolic abnormalities, including abdominal obesity, dyslipidemia, elevated plasma glucose, and insulin resistance, which are the main features of the metabolic syndrome. The metabolic syndrome is extremely common worldwide. This high prevalence is of considerable concern because several studies suggest that the metabolic syndrome carries an increased risk for cardiovascular events. Several lines of evidence seem to indicate that the metabolic syndrome is associated with an increased prevalence of preclinical cardiovascular and renal changes, such as left ventricular hypertrophy, microalbuminuria, impaired aortic elasticity, and early ca…

arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismLeft ventricular hypertrophyRisk AssessmentInsulin resistanceRisk Factorstarget organ damageInternal medicinePrevalenceInternal MedicinemedicineHumansAbdominal obesityReview Paperbusiness.industrymedicine.diseaseMetabolic syndromeBlood pressureCardiovascular DiseasesHypertensionCardiologyMicroalbuminuriaMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessDyslipidemiaThe Journal of Clinical Hypertension
researchProduct

Binge eating and obesity

2018

Despite there being several pathways leading to obesity [1], there is evidence that binge eating may be an important contributor to its development [2]. Excessive food consumption without compensation increases the risk for the development of obesity, which in turn is associated with numerous complications [3]. Obesity has been found to develop several years after the onset of binge eating, and individuals who were overweight prior to the onset of binge eating tend to gain even more weight during adulthood [4]. Binge eating is defined as eating a larger amount of food than normal during a short period of time (within any 2‐hour period) and, during this time, experiencing a loss of control o…

binge eating disorder obesity intervention
researchProduct

the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells

2009

breast cancer obesity
researchProduct

2021

The aim of the study was to analyze sleep duration and behaviors in relation to psychological parameters in children and adolescents with obesity seeking inpatient weight-loss treatment in comparison to normal-weight children, and whether or not these variables would improve during the time course of treatment. Sixty children or adolescents with overweight and obesity (OBE) and 27 normal-weight (NW) peers (age: 9–17) were assessed for subjective sleep measures through self-reported and parent-reported questionnaires, as well as body weight, body composition, and psychological questionnaires. The OBE participants were assessed upon admission and before discharge of an inpatient multidiscipli…

business.industry030209 endocrinology & metabolismOverweightmedicine.diseaseSleep in non-human animalsObesityChildhood obesity03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineTime coursemedicineAnxiety030212 general & internal medicinemedicine.symptombusinessWeight statusDepression (differential diagnoses)Clinical psychologyFrontiers in Psychiatry
researchProduct

Relación del Índice de Masa Corporal elevado asociado a la postura del pie y la actividad deportiva en la edad pediátrica

2019

[Resumen] Objetivos: Establecer el tipo de pie y el Índice de Masa Corporal que predomina en la edad pediátrica. Material y métodos: Se ha realizado una descriptiva de la muestra estudio analizando la prueba del Foot Posture Índex y el Índice de Masa Corporal a 31 sujetos de 8 años. También se ha analizado la actividad deportiva y la frecuencia con la que se realiza además de valorar si llevaban tratamiento ortopodológico. Resultados: El 50% de la muestra presenta pies pronados. El Índice de Masa Corporal es mayor en el sexo masculino, siendo el 30% de los sujetos los que presentan sobrepeso y el 12% de la muestra obesidad. Conclusiones: No se puede concluir que los pacientes con un Índice …

business.industry030209 endocrinology & metabolismÍndice de masa corporal030204 cardiovascular system & hematologyFoot posture IndexObesidad infantilÍndice de postura del pie03 medical and health sciences0302 clinical medicineMedicineChildhood obesitySports activitybusinessHumanitiesBody mass indexEuropean Journal of Podiatry / Revista Europea de Podología
researchProduct

Novel anti-obesity drugs and plasma lipids

2014

Obesity is a health problem of global, epidemic proportions and a major risk factor for chronic diseases resulting in accelerated morbidity and mortality. Dyslipidemia with a predominance of small dense LDL, impaired functionality of HDL particles, and increased serum levels of remnant particles due to impaired clearance of triglyceriderich lipoproteins significantly heightens cardiovascular events in obese subjects. Pharmacotherapy in combination with lifestyle modification is the primary approach to reduce obesity-related cardiovascular risk. Although there are several potential anti-obesity drugs, orlistat is the only agent that remains available in the market. Lorcaserin and Qsymia ® , …

business.industryEndocrinology Diabetes and MetabolismTherapeutic effectPharmacologymedicine.diseaseObesityanti-obesity drugs contrave dyslipidemia lorcaserin low-density lipoprotein obesity Qsymia® triglycerideLorcaserinOrlistatPharmacotherapymedicineRisk factorCardiology and Cardiovascular MedicineAdverse effectbusinessDyslipidemiamedicine.drug
researchProduct